Lycopodium Limited

PINK:LYOPF USA Engineering & Construction
Market Cap
$339.78 Million
Market Cap Rank
#14676 Global
#5870 in USA
Share Price
$8.55
Change (1 day)
+0.00%
52-Week Range
$8.49 - $8.55
All Time High
$8.55
About

Lycopodium Limited provides engineering and project delivery services in the resources, rail infrastructure, and industrial processes sectors in Australia. It operates through four segments: Resources, Industrial Process, Rail Infrastructure, and Others. The company offers engineering and related services, including process plant and equipment, civil building works, control systems, services, and… Read more

Lycopodium Limited (LYOPF) - Net Assets

Latest net assets as of December 2025: $158.40 Million USD

Based on the latest financial reports, Lycopodium Limited (LYOPF) has net assets worth $158.40 Million USD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($264.22 Million) and total liabilities ($105.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $158.40 Million
% of Total Assets 59.95%
Annual Growth Rate 11.03%
5-Year Change 71.63%
10-Year Change 133.9%
Growth Volatility 8.88

Lycopodium Limited - Net Assets Trend (2004–2025)

This chart illustrates how Lycopodium Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Lycopodium Limited (2004–2025)

The table below shows the annual net assets of Lycopodium Limited from 2004 to 2025.

Year Net Assets Change
2025-06-30 $150.47 Million +18.07%
2024-06-30 $127.44 Million +12.81%
2023-06-30 $112.96 Million +13.33%
2022-06-30 $99.68 Million +13.69%
2021-06-30 $87.67 Million +12.63%
2020-06-30 $77.84 Million -1.98%
2019-06-30 $79.42 Million +0.09%
2018-06-30 $79.35 Million +14.63%
2017-06-30 $69.22 Million +7.60%
2016-06-30 $64.33 Million +1.74%
2015-06-30 $63.23 Million +0.56%
2014-06-30 $62.88 Million -9.43%
2013-06-30 $69.43 Million +15.95%
2012-06-30 $59.88 Million +20.51%
2011-06-30 $49.69 Million +11.11%
2010-06-30 $44.72 Million +12.57%
2009-06-30 $39.73 Million +17.36%
2008-06-30 $33.85 Million +19.58%
2007-06-30 $28.31 Million +12.06%
2006-06-30 $25.26 Million +14.93%
2005-06-30 $21.98 Million +31.40%
2004-06-30 $16.73 Million --

Equity Component Analysis

This analysis shows how different components contribute to Lycopodium Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 170800.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Retained Earnings $140.14 Million 92.28%
Common Stock $13.96 Million 9.19%
Other Comprehensive Income $-2.23 Million -1.47%
Total Equity $151.87 Million 100.00%

Lycopodium Limited Competitors by Market Cap

The table below lists competitors of Lycopodium Limited ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Lycopodium Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 128,064,949 to 151,865,178, a change of 23,800,229 (18.6%).
  • Net income of 42,217,709 contributed positively to equity growth.
  • Dividend payments of 19,870,113 reduced retained earnings.
  • Share repurchases of 1,926,953 reduced equity.
  • Other comprehensive income increased equity by 3,379,586.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $42.22 Million +27.8%
Dividends Paid $19.87 Million -13.08%
Share Repurchases $1.93 Million -1.27%
Other Comprehensive Income $3.38 Million +2.23%
Total Change $- 18.58%

Book Value vs Market Value Analysis

This analysis compares Lycopodium Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.24x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 18.78x to 2.24x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-06-30 $0.46 $8.55 x
2005-06-30 $0.67 $8.55 x
2006-06-30 $0.67 $8.55 x
2007-06-30 $0.75 $8.55 x
2008-06-30 $0.89 $8.55 x
2009-06-30 $1.03 $8.55 x
2010-06-30 $1.15 $8.55 x
2011-06-30 $1.28 $8.55 x
2012-06-30 $1.51 $8.55 x
2013-06-30 $1.74 $8.55 x
2014-06-30 $1.58 $8.55 x
2015-06-30 $1.51 $8.55 x
2016-06-30 $1.54 $8.55 x
2017-06-30 $1.67 $8.55 x
2018-06-30 $1.92 $8.55 x
2019-06-30 $2.01 $8.55 x
2020-06-30 $1.97 $8.55 x
2021-06-30 $2.21 $8.55 x
2022-06-30 $2.53 $8.55 x
2023-06-30 $2.88 $8.55 x
2024-06-30 $3.22 $8.55 x
2025-06-30 $3.82 $8.55 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Lycopodium Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 27.80%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 12.64%
  • • Asset Turnover: 1.39x
  • • Equity Multiplier: 1.59x
  • Recent ROE (27.80%) is above the historical average (23.09%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -1.22% -0.38% 1.60x 1.98x $-1.88 Million
2005 -1.03% -0.33% 1.95x 1.59x $-2.42 Million
2006 30.06% 9.11% 1.96x 1.68x $5.07 Million
2007 31.43% 8.58% 2.13x 1.72x $6.07 Million
2008 36.86% 10.43% 2.10x 1.68x $9.09 Million
2009 36.22% 9.71% 2.28x 1.63x $10.26 Million
2010 35.91% 13.42% 1.78x 1.50x $11.59 Million
2011 34.51% 10.18% 2.01x 1.69x $12.19 Million
2012 37.08% 9.59% 2.28x 1.70x $16.17 Million
2013 31.91% 8.95% 2.03x 1.76x $15.06 Million
2014 6.23% 2.51% 1.90x 1.31x $-2.35 Million
2015 -1.52% -0.75% 1.46x 1.39x $-6.95 Million
2016 5.16% 2.54% 1.43x 1.42x $-2.96 Million
2017 15.54% 4.75% 1.51x 2.16x $3.67 Million
2018 23.79% 9.43% 1.36x 1.85x $10.53 Million
2019 20.67% 10.84% 1.27x 1.50x $8.52 Million
2020 15.04% 5.71% 1.32x 2.00x $3.95 Million
2021 16.07% 8.98% 0.93x 1.92x $5.36 Million
2022 27.04% 11.88% 1.02x 2.23x $17.13 Million
2023 40.81% 14.44% 1.47x 1.92x $35.32 Million
2024 39.60% 14.72% 1.59x 1.69x $37.91 Million
2025 27.80% 12.64% 1.39x 1.59x $27.03 Million

Industry Comparison

This section compares Lycopodium Limited's net assets metrics with peer companies in the Engineering & Construction industry.

Industry Context

  • Industry: Engineering & Construction
  • Average net assets among peers: $1,646,543,800
  • Average return on equity (ROE) among peers: 16.91%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Lycopodium Limited (LYOPF) $158.40 Million -1.22% 0.67x $214.50 Million
Arcosa Inc (ACA) $2.43 Billion 3.86% 1.02x $5.06 Billion
Aecom Technology Corporation (ACM) $-181.00 Million 0.00% 0.00x $11.42 Billion
ACS Actividades de Construcción y Servicios S.A (ACSAF) $4.44 Billion 29.55% 6.70x $8.35 Billion
Acciona S.A (ACXIF) $6.30 Billion 7.00% 2.58x $3.04 Billion
Aecon Group Inc (AEGXF) $153.60 Million 7.49% 3.66x $737.44 Million
ÅF Pöyry AB (publ) (AFXXF) $551.78 Million 41.72% 1.52x $1.66 Billion
Abengoa S.A (AGOAF) $797.49 Million 15.10% 9.17x $1.82 Million
AF Gruppen ASA (AGRUF) $1.95 Billion 35.44% 2.36x $547.02 Million
Argan Inc (AGX) $3.70 Million 24.32% 1.27x $6.30 Billion
Amelco Corporation (AMLC) $15.28 Million 4.60% 1.62x $2.84